BOLT Bolt Biotherapeutics: Forvard P/S multiplikatori
Solid o'smalar terapiyasiga bo'lgan yuqori qondirilmagan talab Bolt Biotherapeutics (BOLT) uchun a’lo imkoniyatlarni yaratadi. Kutilayotgan P/S tendentsiyasi biznesning bozor qiymatini aks ettiradi, bunda 2.40 ushbu ko'rsatkichning joriy qiymatini ko'rsatadi. Bolt Biotherapeutics saraton bilan kurashish uchun AQShdagi o'z markazlaridan va noyob Boltbody texnologiyasidan foydalangan holda, immun aktivatsiyasi uchun innovatsion ISAC-konjugatlarini joriy qilmoqda.
boltbio.com (BOLT) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning xususiy kapitalga nisbati Bolt Biotherapeutics|BOLT - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|BOLT - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar Bolt Biotherapeutics|BOLT - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzlari Bolt Biotherapeutics|Tezkor likvidlik boltbio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
BOLT - Kompaniyaning sof daromadi|Kelajakdagi foyda Bolt Biotherapeutics|BOLT - Bozor narxining sof foydaga nisbati|Forvard P/E multiplikatori Bolt Biotherapeutics, Inc.|BOLT - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|EV/EBITDA multiplikatori Bolt Biotherapeutics|BOLT - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Bolt Biotherapeutics|BOLT - Sirpanuvchi yil uchun bir aksiya uchun foyda|Choraklik EPS foyda o'sishi boltbio.com|BOLT - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Bolt Biotherapeutics
- tushum va sotuvlar tafsilotlari:
Kompaniyaning jamlanma tahlili:Bolt Bio BOLT
Forward P/S ko'rsatkichi Bolt Biotherapeutics (BOLT) kompaniyasining bozor qiymatini kutilayotgan tushumlar nisbatida aks ettiradi, bu esa bozor kapitalizatsiyasining prognoz qilingan savdolarga nisbati orqali aktivning haddan tashqari qimmat baholanganligini aniqlash imkonini beradi. Forward P/S darajasini tahlil qilish orqali investor ISAC platformasining kengayish salohiyatini baholaydi, bunda yuqori R&D xarajatlaridan so'ng, antitelar biosintezining past o'zgaruvchan xarajatlari dori vositasi bozorga kirganidan keyin multiplikatorni keskin kamaytirishi mumkin.
Bolt Biotherapeutics kimlar bilan raqobatlashadi
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|ADMA: Narxning prognoz qilingan daromadga nisbati|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati immunovant.com (IMVT)|Narxning prognoz qilingan daromadga nisbati Kiniksa|Narxning prognoz qilingan daromadga nisbati GRFS|Forvard narx/daromad multiplikatori ADPT (Adaptive Biotechnologies Corp)|Narxning kutilayotgan daromadga nisbati CLDX|Aurinia Pharmaceuticals - Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx BCRX|Vera Therapeutics - Forvard P/S multiplikatori|DNTH: Narxning prognoz qilingan daromadga nisbati|PHVS: Forvard P/S multiplikatori|ABCL - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Tourmaline Bio, Inc.|Bozor kapitallashuvining kelajakdagi daromadga nisbati precigen.com PGEN|Forvard narx/daromad multiplikatori PHAR (Pharming Group)|Narxning kutilayotgan daromadga nisbati NKTR|Forvard P/S multiplikatori UPB (Upstream Bio Corp)|Sotuvga nisbatan forvard narx ZBIO|Immunome, Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati gossamerbio.com|KalVista Pharmaceuticals, Inc. (KALV) - Narxning prognoz qilingan daromadga nisbati|Septerna, Inc. - Sotuvga nisbatan forvard narx|PVLA (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Savara Pharma|Narxning prognoz qilingan daromadga nisbati Rigel Pharmaceuticals (RIGL)|ANAB: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ATXS (Astria Therapeutics, Inc.)|enGene Holdings Inc (ENGN) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|RAPT: Forvard narx/daromad multiplikatori|JBIO - Forvard P/S multiplikatori|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|KYTX: Narxning kutilayotgan daromadga nisbati|TLSA (Tiziana Life Sciences Ltd) - Forvard P/S multiplikatori|Cabaletta Bio Inc. (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard P/S multiplikatori VTYX|Forvard narx/daromad multiplikatori Theratechnologies, Inc THTX|Narxning prognoz qilingan daromadga nisbati Avalo Therapeutics, Inc AVTX|Kapitalizatsiyaning kutilayotgan sotuvga nisbati eledon.com (ELDN)|Agenus Inc. - Forvard P/S multiplikatori|CLYM: Narxning prognoz qilingan daromadga nisbati|Zura Bio Limited (ZURA) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati aTyr Pharmaceuticals (ATYR)|Narxning prognoz qilingan daromadga nisbati Adagene Inc|Narxning prognoz qilingan daromadga nisbati IMA|Forvard narx/daromad multiplikatori STTK (Shattuck Labs, Inc.)|Narxning kutilayotgan daromadga nisbati EQ|Narxning prognoz qilingan daromadga nisbati Connect Biopharma Holdings Limited CNTB|IMUX (Immunic Therapeutics) - Kelajakdagi narxning daromadga nisbati|Atara Biotherapeutics Inc - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx IFRX (InflaRx N.V.)|XFOR: Forvard P/S multiplikatori|Adicet Bio, Inc. (ACET) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Celularity Inc|INMB: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics (BRNS)|Forvard narx/daromad multiplikatori kezarlifesciences.com KZR|Forvard P/S multiplikatori SABS (SAB Biotherapeutics, Inc.)|Forvard P/S multiplikatori Akari Therapeutics PLC AKTX|ENLV: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx QTTB (Q32 Bio Inc.)|GOVX: Forvard P/S multiplikatori|EDSA - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati iBio|Forvard narx/daromad multiplikatori Carisma Tx (CARM)|Narxning prognoz qilingan daromadga nisbati XTL Biopharmaceuticals, Ltd. (XTLB)|Forvard narx/daromad multiplikatori hcwbiologics.com HCWB|Aptevo Therapeutics Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori AIM ImmunoTech, Inc. AIM|ADTX - Narxning prognoz qilingan daromadga nisbati|GRI (GRI Bio Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|XRTX: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vyome Therapeutics (HIND)|REVB (Revelation Biosciences) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati INDP|Narxning prognoz qilingan daromadga nisbati Scinai Immunotherapeutics Ltd. (SCNI)|CALI - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Affimed N.V. AFMD|Allakos Inc - Narxning prognoz qilingan daromadga nisbati|HOOK: Forvard narx/daromad multiplikatori|IGM Biosciences, Inc. - Narxning kutilayotgan daromadga nisbati|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Inc - Sotuvga nisbatan forvard narx|TCBP (TC BioPharm (Holdings) PLC) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati THRD
